Bioidentical hormone replacement therapy

BodyLogicMD Expands Telemedicine Bioidentical Hormone Replacement Therapy (BHRT) to New York and Wisconsin Hormone Patients

Retrieved on: 
Wednesday, January 24, 2024
Woman, Patient, Hypogonadism, MD, Hormone, Adrenal fatigue, Menopause, Bioidentical hormone replacement therapy, Quality of life, Thyroid, Human, Medicine, Telehealth, BHRT, BOCA, Birth control

BOCA RATON, Fla., Jan. 24, 2024 /PRNewswire/ -- BodyLogicMD, a leading provider of bioidentical hormone replacement therapy (BHRT), integrative medicine and weight loss treatment, announced it now offers telemedicine appointments to hormone patients in the entire states of New York and Wisconsin.

Key Points: 
  • BOCA RATON, Fla., Jan. 24, 2024 /PRNewswire/ -- BodyLogicMD, a leading provider of bioidentical hormone replacement therapy (BHRT), integrative medicine and weight loss treatment, announced it now offers telemedicine appointments to hormone patients in the entire states of New York and Wisconsin.
  • "BodyLogicMD practitioners are bioidentical hormone replacement therapy experts," Jennifer Landa, MD, BodyLogicMD Chief Medical Officer, said.
  • Telemedicine offers hormone patients the convenience of being treated from virtually anywhere by one of our hormone experts.
  • Bioidentical hormone replacement therapy (BHRT) uses hormones that are molecularly identical to those produced in humans.

Besins Healthcare Unveils State-of-the-Art Hormone Factory in Muel, Spain, Amplifying Global Production Capabilities by 30%

Retrieved on: 
Wednesday, September 27, 2023
Estrogen, Water supply and sanitation in the European Union, Besins Healthcare, Bioidentical hormone replacement therapy, Progesterone, Woman, HRT, Acquisition, Patient, Fertility, Menopause, Hormone, News, Birth control

MONACO, Sept. 26, 2023 /PRNewswire/ -- Besins Healthcare, a global lead in Women's and Men's Reproductive Health, today unveiled its novel hormone production facility in Muel, situated near Zaragoza, Spain. This event represents a significant moment in European pharmaceutical history.

Key Points: 
  • MONACO, Sept. 26, 2023 /PRNewswire/ -- Besins Healthcare, a global lead in Women's and Men's Reproductive Health, today unveiled its novel hormone production facility in Muel, situated near Zaragoza, Spain.
  • Built in an astounding time frame since its foundation in mid-2022, this avant-garde facility adheres to the highest quality complying with the highest environmental standards.
  • The plant fortifies Besins Healthcare's commitment to scale up production capacities within Europe, boosting their output by an impressive 30%.
  • Following its strategic acquisition of a hormone production site in Drogenbos, Belgium, in 2022, Besins Healthcare continues to reinforce its commitment to the European Union's initiative to mitigate drug shortages and establish pharmaceutical sovereignty (1).

Wellcore Introduces Pain-Free, At-Home Hormone Optimization Program for Women

Retrieved on: 
Thursday, June 29, 2023
DHEA, Bioidentical hormone replacement therapy, Hormone replacement therapy, Osteoporosis, Clinical trial, Medicine, Brain, Estradiol, Attention, Libido, Biomarker, Weight gain, Hot, WHI, Sleep, HRT, Capsule, Cancer, Testosterone, Progesterone, Pain, Safety, Birth control, Woman

AUSTIN, Texas, June 29, 2023 /PRNewswire/ -- Wellcore, a science-backed at-home hormone optimization program for men, has introduced a women's program built on the same principles: wellness, accessibility, personalization and most importantly, safety. The comprehensive program elevates industry standards by providing painless at-home hormone assessments along with ongoing, proactive testing of 22 biomarkers. This helps identify imbalances with more accuracy than other at-home services, which are then treated with a personalized hormone optimization protocol.

Key Points: 
  • The comprehensive program elevates industry standards by providing painless at-home hormone assessments along with ongoing, proactive testing of 22 biomarkers.
  • This helps identify imbalances with more accuracy than other at-home services, which are then treated with a personalized hormone optimization protocol.
  • The Wellcore women's program is currently available in Alaska, Arizona, California, Minnesota, Nevada, New Jersey, New York, North Carolina, Pennsylvania and Texas.
  • The all-inclusive hormone optimization program which entails all future lab work, consultations and shipping is $225 per month and billed quarterly.

Getlabs Partners with JumpstartMD to Provide In-Home Phlebotomy Services

Retrieved on: 
Tuesday, September 27, 2022
Jump start, Health, Journal, American Board of Commissioners for Foreign Missions, Weight loss, FDA, American Board of Obesity Medicine, Overweight, Obesity, Partnership, Bioidentical hormone replacement therapy, Program, Patient, CEO, Stanford University, Science, International Journal of Obesity, Health care, Multimedia, Medicine, Dietary supplement, Pharmaceutical industry

Through research-based, medically supervised programs, JumpstartMD offers nutritional science and one-on-one support to change lives.

Key Points: 
  • Through research-based, medically supervised programs, JumpstartMD offers nutritional science and one-on-one support to change lives.
  • "By empowering JumpstartMD members with convenient at-home blood draw services, we can help increase program adherence."
  • JumpstartMD provides recommendations for real food, individualized support from its team of experts, and a scientifically proven approach, which emphasizes health improvements that are easily tracked through Getlabs' in-home phlebotomy service.
  • JumpstartMD provides services including Weight Loss, Bioidentical Hormone Replacement Therapy, Vitamin Therapy and Supplement Therapy.

ACTIVE HEALTH FOODS, INC. COMPLETES “DREAM TEAM” BOARD OF DIRECTORS ADDING DRS. MILLER AND OLIVER

Retrieved on: 
Wednesday, June 29, 2022
OTC, Life, CEO, Bioidentical hormone replacement therapy, American Academy, Functional medicine, RBT, GLOBE, Bioenergetics, Association, Board of High School and Intermediate Education Uttar Pradesh, Empowerment, Founder, American Academy of Anti-Aging Medicine, Disorder, EMBA, CA, Transgender hormone therapy, Board, Physician, MD, BIO, Pharmaceutical industry, Director

Los Angeles, CA, June 29, 2022 (GLOBE NEWSWIRE) -- ACTIVE HEALTH FOODS, INC. (OTC: AHFD) announces that Dr. Philip Lee Miller, of Monterey, California, and Dr. Aubrey Oliver in Jamaica, have joined AHFDs subsidiary Bioidentical Hormones, Inc. (BIO) Board of Directors.

Key Points: 
  • Los Angeles, CA, June 29, 2022 (GLOBE NEWSWIRE) -- ACTIVE HEALTH FOODS, INC. (OTC: AHFD) announces that Dr. Philip Lee Miller, of Monterey, California, and Dr. Aubrey Oliver in Jamaica, have joined AHFDs subsidiary Bioidentical Hormones, Inc. (BIO) Board of Directors.
  • Dr. Miller has become a recognized leader in Anti-Aging integrative medicine.
  • This started with a past association with Dr. Julian Whitaker of the Whitaker Wellness Institute in Newport Beach, California.
  • He passed the first-ever Board Exams in Anti-Aging Medicine in December 1998. www.antiaging.com
    Dr. Aubrey Oliver, Functional Medicine Doctor, Naturopathic Doctor, RBT & EMBA, based in Jamaica.

ACTIVE HEALTH FOODS, INC. COMPLETES “DREAM TEAM” BOARD OF DIRECTORS ADDING DRS. AUBREY AND OLIVER

Retrieved on: 
Wednesday, June 29, 2022
OTC, Life, CEO, Bioidentical hormone replacement therapy, American Academy, Functional medicine, RBT, GLOBE, Bioenergetics, Association, Board of High School and Intermediate Education Uttar Pradesh, Empowerment, Founder, American Academy of Anti-Aging Medicine, Disorder, EMBA, CA, Transgender hormone therapy, Board, Physician, MD, BIO, Pharmaceutical industry, Director

Los Angeles, CA, June 29, 2022 (GLOBE NEWSWIRE) -- ACTIVE HEALTH FOODS, INC. (OTC: AHFD) announces that Dr. Philip Lee Miller, of Monterey, California, and Dr. Aubrey Oliver in Jamaica, have joined AHFDs subsidiary Bioidentical Hormones, Inc. (BIO) Board of Directors.

Key Points: 
  • Los Angeles, CA, June 29, 2022 (GLOBE NEWSWIRE) -- ACTIVE HEALTH FOODS, INC. (OTC: AHFD) announces that Dr. Philip Lee Miller, of Monterey, California, and Dr. Aubrey Oliver in Jamaica, have joined AHFDs subsidiary Bioidentical Hormones, Inc. (BIO) Board of Directors.
  • Dr. Miller has become a recognized leader in Anti-Aging integrative medicine.
  • This started with a past association with Dr. Julian Whitaker of the Whitaker Wellness Institute in Newport Beach, California.
  • He passed the first-ever Board Exams in Anti-Aging Medicine in December 1998. www.antiaging.com
    Dr. Aubrey Oliver, Functional Medicine Doctor, Naturopathic Doctor, RBT & EMBA, based in Jamaica.

ACTIVE HEALTH FOODS, INC. ADDS RESPECTED MEDICAL DOCTORS TO BOARD OF DIRECTORS

Retrieved on: 
Wednesday, June 22, 2022
American Academy, Chief Medical Officers (United Kingdom), Health care, Chris Hani Baragwanath Hospital, Bioidentical hormone replacement therapy, Company, OTC, BIO, Senior management, Medicine, Ownership, GLOBE, University, IHS, CA, Wilderness Medical Society, Anti-aging movement, University of the Witwatersrand, Doctor of Medicine, Telehealth, American Association of Clinical Endocrinologists, BHRT, Patient, Board of directors, Board, Physician, Woman, Luc, Alternative medicine, Management, Pharmaceutical industry, Director

Dr. Thierry Hertoghe, based in Brussels, Belgium, has joined BIO as the Chairman of its Scientific Board of Directors.

Key Points: 
  • Dr. Thierry Hertoghe, based in Brussels, Belgium, has joined BIO as the Chairman of its Scientific Board of Directors.
  • Both of these highly respected Medical Doctors are also substantial shareholders in the Company, representing 22% ownership collectively.
  • www.hertoghemedicalschool.eu
    Joe Wallace, AHFDs President stated, The participation of these highly respected Anti-Aging Medical Doctors in guiding the Active Health business plan as it expands around the world, is invaluable.
  • AHFD will be announcing the other members of its Scientific Board and Board of Directors during the next week.

Spartan Medical Associates Open New Location in Charlotte NC, Treating Men and Women with Hormone Replacement Therapy and TRT

Retrieved on: 
Tuesday, March 15, 2022
Woman, Quality of life, Time, Depression, Progesterone, Hormone replacement therapy, GLOBE, Unit, Patient, Testosterone, Bioidentical hormone replacement therapy, Erectile dysfunction, Weight gain, Motivation, BHRT, Hormone, Fatigue, Outline, Associate, Libido, PCOS, Ageing, Cognition, Mental health, Canadian Medical Association, Weight loss, Man, Travel, Menopause, Industry, Lithium, Birth control, Medical device, Hospital, Pharmaceutical industry

Charlotte, March 15, 2022 (GLOBE NEWSWIRE) -- Leading hormone replacement specialists Spartan Medical Associates, who are based in North Carolina, have today announced the opening of a new treatment location in Charlotte.

Key Points: 
  • Charlotte, March 15, 2022 (GLOBE NEWSWIRE) -- Leading hormone replacement specialists Spartan Medical Associates, who are based in North Carolina, have today announced the opening of a new treatment location in Charlotte.
  • Full details of the newly opened Charlotte medical office can be found on the Spartan Medical Associates website.
  • The treatments provided at the new medical office in Charlotte NC:
    While Spartan Medical Associates provide a broad range of treatments, two of the most popular in Charlotte NC are hormone replacement therapy and testosterone replacement therapy.
  • Spartan Medical Associates specializes in physician managed Bioidentical Hormone Replacement Therapy for men and women to treat menopause/perimenopause, low testosterone in men/women, suboptimal thyroid hormone, PCOS, weight loss and hormone therapy for traumatic brain injury.

Biote CEO Terry S. Weber to Present at Jefferies Healthcare Conference

Retrieved on: 
Wednesday, May 26, 2021
Biotechnology, General Health, Other Health, Health, Pharmaceutical, Medicine, Clinical medicine, Health sciences, Menopause, Bioidentical hormone replacement therapy, Hormone replacement therapy, Transgender hormone therapy, Therapy, Conjugated estrogens, Feminizing hormone therapy, Masculinizing hormone therapy

Biote Medical today announces that CEO Terry S. Weber will present at the Jefferies Virtual Healthcare Conference on June 3 at 9:30 a.m. Eastern time in Track 1.

Key Points: 
  • Biote Medical today announces that CEO Terry S. Weber will present at the Jefferies Virtual Healthcare Conference on June 3 at 9:30 a.m. Eastern time in Track 1.
  • The video presentation will be live streamed, and conference attendees can register via the Jefferies portal.
  • Biote is the leader in bioidentical hormone optimization therapy for men and women and commercializes supporting supplements scientifically formulated to complement hormone performance.
  • Under the leadership of Ms. Weber, Biote advocates for provider and patient access to bioidentical hormone replacement therapy (BHRT) and is committed to the highest standards of science, education, and research.

New Skin Care Line, Orora, Launches Products with the First Bioidentical Human Collagen Ingredient in North America

Retrieved on: 
Wednesday, May 19, 2021
Articles, Structural proteins, Medicine, Branches of biology, Collagen, Veganism, Bioidentical hormone replacement therapy, Type I collagen

a holistic beauty brand dedicated to bringing the most unique and effective ingredients to skincare, launched two products with the first vegan bioidentical human collagen ingredient in North America.\nThe products are formulated with Geltor\'s bioactive human collagen ingredient, HumaColl21, a biodesigned peptide (INCI: sh-polypeptide-121)that works to stimulate the skin\'s natural collagen synthesis.

Key Points: 
  • a holistic beauty brand dedicated to bringing the most unique and effective ingredients to skincare, launched two products with the first vegan bioidentical human collagen ingredient in North America.\nThe products are formulated with Geltor\'s bioactive human collagen ingredient, HumaColl21, a biodesigned peptide (INCI: sh-polypeptide-121)that works to stimulate the skin\'s natural collagen synthesis.
  • "Featuring the firstbioidentical human collagen ingredient and the proven effectiveness of HumaColl21 in beauty products is going to change the way customers experience skincare.
  • Orora partners with cutting-edge science to make the latest innovations accessible for those seeking the next frontier of beauty.
  • Orora launched in 2021 with a product line formulated with the first bioidentical and vegan collagen ingredient in a skincare product line in North America.